Tavapadon

Expanded Access to Tavapadon

Open-label Trial in Parkinson's Disease (PD)

Flexible-Dose Trial in Early Parkinson's Disease (PD)

Fixed-Dose Trial in Early Parkinson's Disease (PD)

A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants

Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function

Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease

To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function

Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants